Texte intégral
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
_____________
No. 15-3475
_____________
IN RE: MODAFINIL ANTITRUST LITIGATION
Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.;
Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc.,
Appellants
______________
On Appeal from the United States District Court
for the Eastern District of Pennsylvania
District Court No. 2-06-cv-01797
District Judge: The Honorable Mitchell S. Goldberg
_________________
Before: SMITH, JORDAN, and RENDELL, Circuit Judges
_________________
ORDER AMENDING OPINION
_________________
The opinion filed September 13, 2016 is amended solely as to the listing of Paul
B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of
the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of
Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the
listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks
in Washington, DC. The opinion is amended as follows:
-- 1 of 2 --
Paul B. Hewitt
C. Fairley Spillman
Catherine E. Creely
Akin Gump Strauss Hauer & Feld
1333 New Hampshire Avenue, N.W.
Suite 400
Washington, DC 20036
For the Court,
Marcia M. Waldron, Clerk
Date: September 29, 2016
PDB/cc: All Counsel of Record
-- 2 of 2 --
